Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn's disease and ulcerative colitis - experiences from a single center

Hasonló tételek

• Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis
  Szerző: Farkas Klaudia, et al.
  Megjelent: (2016)
• Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center
  Szerző: Farkas Klaudia, et al.
  Megjelent: (2017)
• Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort
  Szerző: Bálint Anita, et al.
  Megjelent: (2018)
• Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases a prospective; multicentre; nationwide cohort /
  Szerző: Gecse Krisztina Barbara, et al.
  Megjelent: (2016)
• Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
  Szerző: Miheller Pál, et al.
  Megjelent: (2009)